Saturday, June 3, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

BOSTON - Sarepta Pharmaceuticals inflated its share price with false and misleading statements and the stock fell from $36.56 to $23.40 in a day when the news came out, a shareholder claims in a federal class action.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.